Advanced diagnosis and treatment for prostate cancer
Major advancement in prostate cancer detection
Fusion biopsy, the latest technology for detecting prostate cancer, now offered at Bryan Medical Center.
Prostate cancer is the most common cancer among men in the United States. The American Cancer Society estimates over 220,000 men will be diagnosed with prostate cancer this year. In Nebraska alone, almost 1,200 men will be diagnosed.
Turn to Bryan for early detection and, if needed, cancer treatment.
Our board certified doctors, colorectal surgeons, nurses, pharmacists, oncology nurse navigators and others from your treatment team are here to provide diagnosis, treatment and support you every step of the way.
Studies link the following with increased risk of prostate cancer:
- Above the age of 50
- Occurs more often in African-American men and in Caribbean men of African ancestry
- Family history – having a father or brother with prostate cancer more than doubles your risk; it is higher for those with a brother with prostate cancer than a father with prostate cancer
- Inherited gene changes
- A diet high in red meat or high-fat dairy products
Most prostate cancers are first found during screening with a prostate-specific antigen (PSA) blood test and or a digital rectal exam (DRE). Early prostate cancers usually don’t cause symptoms, but more advanced cancers are sometimes found because of symptoms they cause.
Prostate MRI-Ultrasound Fusion Biopsy
This major advancement in detecting prostate cancer enhances prostate cancer detection by combining detailed, three-dimensional MRI images with real-time ultrasound images of the prostate, allowing very specific targeting and increased accuracy.
Prostate Specific Antigen (PSA) blood test
Most healthy men have PSA levels under four nanograms per milliliter (ng/mL) of blood. The chance of having prostate cancer goes up as the PSA level goes up.
Transrectal Ultrasound (TRUS)
A small probe is inserted into your rectum to show images of the prostate. It is also used to guide the needles into the prostate during a biopsy.
Core Needle Biopsy
A small, hollow needle is inserted through the wall of the rectum into the prostate to obtain tissue samples. This is repeated eight to 18 times in various parts of the prostate. The transrectal ultrasound may be used to guide the needle.
The following tests may be ordered to detect the spread of prostate cancer:
Treatment and Therapies
With an accurate diagnosis and knowing the stage of your prostate cancer, you and your doctor will discuss treatment options and choose a treatment plan that is right for you.
The treatment you choose for prostate cancer should take into account:
- Your age
- Any other serious health conditions you have
- The stage and grade of your cancer
- Your feelings (and your doctor’s opinion) about the need to treat the cancer right away
- The likelihood that each type of treatment will cure your cancer or help in some other way
- Your thoughts about the possible side effects from each treatment, which will be explained by your doctor
Your Treatment Options
Because prostate cancer often grows very slowly, some men, especially those who are older or have other serious health problems might never need treatment for their prostate cancer.
Active surveillance involves monitoring the cancer closely with prostate-specific antigen (PSA) blood tests, digital rectal exams (DREs) and ultrasounds over regular time periods to see if the cancer is growing. Prostate biopsies may be done to see if the cancer is becoming more aggressive. If your test results show cancer growth, your doctor will talk to you about treatment options.
Learn more about surgery options.